Information Library
Results for: Cost control/reduction - Lower portfolio & investment risks
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Population PK/PD - Modeling and Simulation Optimization Tools
Brochure — February 11, 2011
Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling. -
Consulting – Breakthrough Thinking Built on Experience
Brochure — November 23, 2010
Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today. -
Managing Pharmacovigilance as a Business
White Paper — July 28, 2010
The three steps required to develop a strategic approach to global capacity management. -
Jim Featherstone, Ph.D.
Hear from the Experts — March 25, 2009
Jim joined Quintiles Consulting from Wood Mackenzie, a leading business intelligence and strategy consulting services company based in the UK, where he was the Global Head of Consulting for the Pharmaceuticals and Biotechnology practice. -
Podcast: A New Gold Standard
Hear from the Experts — May 1, 2008
John Doyle discusses the concept of a health economic balance sheet and the need for evidence-based pricing for biopharmaceutical valuation.
Page 1 of 1 (5 results)
